← The Wire
VERANasdaq
Vera Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1831828
Develops transformative treatments for serious immunological diseases, including atacicept for autoimmune conditions
$2.46B
Market cap
$43.15
Last close
+1.6%
1D
+12.3%
5D
3.4M
Volume
Price · last 39 sessions+21.5%
May 4L $31.26 · H $43.15Jun 29
123
Total filings
Jun 2, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateJun 2, 20268-KShareholder VoteMay 26, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 9, 2026DEF 14ADEF 14AApr 9, 20268-KExecutive ChangeMar 9, 2026SC 13D/ASC 13D/AMar 5, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KExecutive ChangeDec 18, 20258-KCompany UpdateDec 10, 2025424B5424B5Dec 10, 2025424B5424B5Dec 8, 20258-KExecutive ChangeNov 26, 20258-KCompany UpdateNov 6, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KMaterial Agreement · Agreement TerminatedAug 5, 2025424B5424B5Aug 5, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KMaterial Agreement · New Debt / ObligationJun 3, 20258-KReg FD Disclosure · Company UpdateJun 2, 20258-KShareholder VoteMay 19, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 3, 2025DEF 14ADEF 14AApr 3, 202510-K10-KFeb 28, 20258-KResults of OperationsFeb 26, 20258-KReg FD DisclosureJan 13, 2025SC 13GSC 13GNov 14, 2024SC 13GVERA THERAPEUTICS, INC.Nov 14, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 20248-KCompany UpdateOct 31, 2024424B5424B5Oct 30, 2024424B5424B5Oct 29, 20248-KResults of Operations · Reg FD DisclosureOct 28, 20248-KReg FD DisclosureOct 2, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KExecutive ChangeJul 2, 20248-KExecutive ChangeJun 12, 20248-KShareholder VoteMay 17, 202410-Q10-QMay 10, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AMay 3, 2024DEFA14ADEFA14AApr 3, 2024DEF 14ADEF 14AApr 3, 202410-K10-KMar 27, 20248-KResults of OperationsMar 20, 2024SC 13GSC 13GFeb 12, 20248-KCompany UpdateJan 30, 2024424B5424B5Jan 30, 2024SC 13GSC 13GJan 29, 2024424B5424B5Jan 29, 20248-KResults of Operations · Company UpdateJan 29, 20248-KReg FD Disclosure · Company UpdateJan 25, 20248-KExecutive Change · Reg FD DisclosureJan 8, 20248-KReg FD DisclosureJan 8, 20248-KNew Debt / ObligationDec 26, 202310-Q10-QNov 9, 20238-KResults of OperationsNov 9, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KReg FD Disclosure · Company UpdateJun 20, 20238-KShareholder VoteMay 17, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEFA14ADEFA14AMar 30, 2023DEF 14ADEF14AMar 30, 202310-K10-KMar 28, 20238-KResults of OperationsMar 28, 20238-KCompany UpdateMar 10, 2023SC 13GSC 13GFeb 16, 2023SC 13GKYNAM CAPITAL MANAGEMENT, LPFeb 10, 20238-KCompany UpdateFeb 2, 2023424B5424B5Feb 2, 2023
Insider Activity
In the 90 days to Feb 23, 2026: 1 insider bought $250K · 7 sold $2.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sell | 16,925 | $41.98 | $711K |
| Feb 23, 2026 | Grant SeanCHIEF FINANCIAL OFFICER | Sell | 4,949 | $41.98 | $208K |
| Feb 23, 2026 | Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | Sell | 3,117 | $41.98 | $131K |
| Feb 23, 2026 | Johnson David LeeChief Operating Officer | Sell | 2,579 | $41.98 | $108K |
| Feb 23, 2026 | Turner William D.Chief Regulatory Officer | Sell | 2,187 | $41.98 | $92K |
| Feb 23, 2026 | Brenner RobertChief Medical Officer | Sell | 2,151 | $41.98 | $90K |
| Feb 23, 2026 | Skelton Laurence MatthewChief Commercial Officer | Sell | 1,582 | $41.98 | $66K |
| Dec 15, 2025 | Turner William D.Chief Regulatory Officer | Sell | 10,000 | $50.08 | $501K |
| Dec 11, 2025 | Enright Patrick GDirector | Buy | 5,882 | $42.50 | $250K |
| Dec 8, 2025 | Turner William D.Chief Regulatory Officer | Sell | 10,000 | $45.31 | $453K |
| Dec 3, 2025 | Turner William D.Chief Regulatory Officer | Sell | 10,000 | $40.00 | $400K |
| Nov 21, 2025 | Carter Jason SChief Legal Officer | Sell | 3,864 | $27.82 | $107K |
| Nov 11, 2025 | Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | Sell | 15,000 | $29.06 | $436K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance